Moreover, BDNF/TrkB signaling has been implicated in tumor progression, metastasis, and chemotherapy response across several human malignancies including neuroblastoma, ovarian, head and neck, lung, and colorectal cancer (76). This evidence concerns the gene NTRK2 and colorectal cancer.